- Home
- IXHL vs THCH Comparison
IXHL vs THCH Comparison
Compare IXHL & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | IXHL | THCH |
|---|---|---|
| Founded | 2001 | 2018 |
| Country | Australia | China |
| Employees | 12 | N/A |
| Industry | | Blank Checks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.4M | 37.2M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IXHL | THCH |
|---|---|---|
| Price | $2.77 | $1.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 54.6K | 5.9K |
| Earning Date | 11-13-2026 | 12-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $1.00 |
| 52 Week High | $6.39 | $3.25 |
Technical Indicators
Market Signals| Indicator | IXHL | THCH |
|---|---|---|
| Relative Strength Index (RSI) | 30.81 | 40.49 |
| Support Level | $2.79 | N/A |
| Resistance Level | $3.89 | $2.27 |
| Average True Range (ATR) | 0.13 | 0.05 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 6.65 | 15.25 |
Price Performance
Historical ComparisonAbout IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical-stage biopharmaceutical development company dedicated to developing inventive medicines for patients living with serious chronic diseases and unmet needs. The Company's drug candidates include IHL-42X for the treatment of obstructive sleep apnea (OSA) and PSX-001, the Company's psilocybin treatment in combination with psychological therapy in development to treat patients with generalized anxiety disorder (GAD). The Company also has a drug candidate, IHL-675A, for the treatment of rheumatoid arthritis. Each of these programs target conditions that currently have limited, inadequate, or no approved pharmaceutical treatment options. The Company continues to evaluate strategies for IHL-675A when and as resources permit.
About THCH TH International Limited Ordinary shares
TH International Ltd is the exclusive master franchisee in China for Tim Hortons, a world-wide coffee and bakery shop brand. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under a single reportable segment, Tim Hortons. The company's revenue is derived from sales of food, beverages, and packaged products by company-owned and operated stores, franchise fees, and revenue from other franchise support activities. Its geographic revenue is derived from operations in the PRC.